Cargando…

Cost-effectiveness of transplanting lungs and kidneys from donors with potential hepatitis C exposure or infection

Organ transplant guidelines in many settings recommend that people with potential hepatitis C virus (HCV) exposure or infection are deemed ineligible to donate. The recent availability of highly-effective treatments for HCV means that this may no longer be necessary. We used a mathematical model to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scott, Nick, Snell, Greg, Westall, Glen, Pilcher, David, Raggatt, Michelle, Walker, Rowan G., Hellard, Margaret, Peleg, Anton Y., Doyle, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989464/ https://www.ncbi.nlm.nih.gov/pubmed/31996734 http://dx.doi.org/10.1038/s41598-020-58215-z

Ejemplares similares

A spirometric journey following lung transplantation
por: Fuller, Jeremy, et al.
Publicado: (2014)

Challenges inherent to the diagnosis of antibody-mediated rejection in lung transplantation
por: Chin, Nicholas, et al.
Publicado: (2015)

Determining Clinical Thresholds for Donor HLA Eplet Compatibility to Predict Best Outcomes Following Lung Transplantation
por: Hiho, Steven J., et al.
Publicado: (2022)

Impact of Commonly Used Transplant Immunosuppressive Drugs on Human NK Cell Function Is Dependent upon Stimulation Condition
por: Meehan, Aislin C., et al.
Publicado: (2013)

The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients
por: Woolley, Ann E., et al.
Publicado: (2022)

The complex existence of γδ T cells following transplantation: the good, the bad and the simply confusing
por: Sullivan, Lucy C, et al.
Publicado: (2019)

Activin Biology After Lung Transplantation
por: Westall, Glen P., et al.
Publicado: (2017)

Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts
por: Millard, Susan M., et al.
Publicado: (2015)

Identifying the Most Effective Recruitment Strategy Using Financial Reimbursements for a Web-Based Peer Network Study With Young People Aged 16-18 Years: Protocol for a Randomized Controlled Trial
por: Raggatt, Michelle, et al.
Publicado: (2023)

Effectiveness of an Ecological Momentary Intervention for Reducing Risky Alcohol Consumption Among Young Adults: Protocol for a Three-Arm Randomized Controlled Trial
por: Wright, Cassandra, et al.
Publicado: (2020)

Exposure to Pornography and Adolescent Sexual Behavior: Systematic Review
por: Pathmendra, Pranujan, et al.
Publicado: (2023)

A systematic review of community based hepatitis C treatment
por: Wade, Amanda J., et al.
Publicado: (2016)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
por: Scott, Nick, et al.
Publicado: (2021)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
por: Scott, Nick, et al.
Publicado: (2018)

Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis
por: Lim, Aaron G., et al.
Publicado: (2021)

Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
por: Goutzamanis, Stelliana, et al.
Publicado: (2021)

“Like a pickle that’s been unpickled”: Emotional, identity and behavioural transformations throughout hepatitis C treatment
por: Goutzamanis, Stelliana, et al.
Publicado: (2022)

Use of hepatitis C-positive donors in transplantation
por: Abdala, Edson, et al.
Publicado: (2012)

Living-Donor Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2013)

Kidney Transplantation From Donors with Hepatitis B
por: Veroux, Massimiliano, et al.
Publicado: (2016)

Challenges and costs of donor screening for fecal microbiota transplantations
por: Bénard, Mèlanie V., et al.
Publicado: (2022)

Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study
por: Scott, Dr Nick, et al.
Publicado: (2021)

Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.
por: El-Meteini, Mahmoud, et al.
Publicado: (2014)

Evaluating the potential cost-effectiveness of microarray patches to expand access to hepatitis B birth dose vaccination in low-and middle-income countries: A modelling study
por: Seaman, Christopher P., et al.
Publicado: (2022)

Eliminating hepatitis C virus as a public health threat among HIV‐positive men who have sex with men: a multi‐modelling approach to understand differences in sexual risk behaviour
por: Scott, Nick, et al.
Publicado: (2018)

Eradication of hepatitis C infection: The importance of targeting people who inject drugs
por: Hellard, Margaret, et al.
Publicado: (2014)

Australia needs to increase testing to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2020)

Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
por: Win, Thin Mar, et al.
Publicado: (2023)

Living donor liver transplantation for intra hepatic cholangiocarcinoma
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2020)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation
por: Chung, Jae Hun, et al.
Publicado: (2020)

Methodological challenges in appraising evidence on diagnostic testing for WHO guidelines on hepatitis B and hepatitis C virus infection
por: Chou, Roger, et al.
Publicado: (2017)

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021)

CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors
por: Azhar, Ambreen, et al.
Publicado: (2022)

Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study
por: Goutzamanis, Stelliana, et al.
Publicado: (2018)

Assessment of organ transplants from donors with markers of hepatitis B
por: Abdala, Edson, et al.
Publicado: (2012)

Clinical implication of hepatic volumetry for living donor liver transplantation
por: Jeong, Woo Kyoung
Publicado: (2018)

Review of heart transplantation from hepatitis C-positive donors
por: Patel, Palak, et al.
Publicado: (2022)

Letter to the Editor: Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective
por: Harney, Brendan, et al.
Publicado: (2020)

Cytomegalovirus replication is associated with enrichment of distinct γδ T cell subsets following lung transplantation: A novel therapeutic approach?
por: Stankovic, Sanda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8od8abq08juialn7e7rnf8c461